| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,110 |
19,974 |
$1.30M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,901 |
5,459 |
$299K |
| 99490 |
Ccm add 20min |
13,827 |
12,722 |
$223K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
3,443 |
2,563 |
$168K |
| 99497 |
|
5,352 |
3,707 |
$150K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,777 |
1,281 |
$92K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,409 |
968 |
$82K |
| 99439 |
|
4,350 |
4,033 |
$74K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,408 |
3,012 |
$58K |
| 96127 |
|
21,303 |
7,306 |
$52K |
| 96160 |
|
13,263 |
7,565 |
$44K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
457 |
351 |
$37K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,400 |
1,452 |
$36K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
338 |
277 |
$34K |
| 99487 |
Ccm add 20min |
1,106 |
1,016 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
683 |
440 |
$16K |
| 3008F |
|
22,619 |
10,430 |
$16K |
| 3078F |
|
9,139 |
5,987 |
$13K |
| 3074F |
|
9,306 |
6,024 |
$12K |
| 93000 |
|
1,247 |
924 |
$12K |
| 90686 |
|
1,093 |
791 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,207 |
837 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
8,614 |
6,214 |
$10K |
| 81002 |
|
6,510 |
4,564 |
$9K |
| 99173 |
|
4,237 |
2,837 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
545 |
200 |
$9K |
| 99406 |
|
1,331 |
876 |
$8K |
| 99457 |
|
571 |
500 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
113 |
73 |
$8K |
| 3079F |
|
3,353 |
2,276 |
$6K |
| 99454 |
|
349 |
289 |
$6K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,017 |
736 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
582 |
234 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
674 |
474 |
$5K |
| 80305 |
|
1,122 |
824 |
$5K |
| 90688 |
|
450 |
311 |
$4K |
| 94760 |
|
8,360 |
5,245 |
$4K |
| 81025 |
|
887 |
614 |
$4K |
| 90682 |
|
95 |
62 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,482 |
1,081 |
$3K |
| 3075F |
|
2,494 |
1,771 |
$3K |
| 3077F |
|
1,166 |
733 |
$3K |
| 0011A |
|
64 |
44 |
$2K |
| 99458 |
|
148 |
128 |
$2K |
| 97802 |
|
54 |
38 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
14 |
$2K |
| 94690 |
|
79 |
49 |
$2K |
| 94060 |
|
65 |
58 |
$2K |
| 99408 |
|
896 |
576 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
67 |
57 |
$1K |
| 90656 |
|
89 |
82 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
75 |
48 |
$962.89 |
| 96161 |
|
180 |
147 |
$937.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
887 |
680 |
$835.36 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,386 |
1,567 |
$807.04 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
1,549 |
1,018 |
$792.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
1,555 |
1,019 |
$784.00 |
| 99051 |
|
232 |
168 |
$758.37 |
| 0012A |
|
18 |
14 |
$739.20 |
| 87400 |
|
98 |
43 |
$587.32 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
387 |
250 |
$567.12 |
| 92551 |
|
81 |
62 |
$473.87 |
| 0013A |
|
16 |
12 |
$467.36 |
| 94016 |
|
49 |
43 |
$410.06 |
| 3080F |
|
135 |
92 |
$390.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
82 |
45 |
$378.77 |
| 97803 |
|
13 |
12 |
$367.31 |
| 90714 |
|
21 |
13 |
$334.56 |
| G9916 |
Functional status performed once in the last 12 months |
1,263 |
888 |
$248.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
14 |
12 |
$223.54 |
| 90662 |
|
161 |
120 |
$176.10 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
14 |
12 |
$161.82 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$128.99 |
| G0008 |
Administration of influenza virus vaccine |
480 |
390 |
$125.82 |
| 99397 |
|
90 |
69 |
$94.21 |
| G2058 |
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). |
114 |
109 |
$65.22 |
| 88142 |
|
14 |
12 |
$51.50 |
| 90461 |
|
66 |
28 |
$23.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
12 |
$13.58 |
| 91301 |
|
192 |
134 |
$0.39 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
32,846 |
21,134 |
$0.02 |
| 1126F |
|
541 |
464 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
4,677 |
3,039 |
$0.00 |
| 1101F |
|
985 |
706 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,885 |
2,737 |
$0.00 |
| G9788 |
Most recent bp is less than or equal to 130/80 mm hg |
997 |
746 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,994 |
2,530 |
$0.00 |
| 1123F |
|
5,049 |
3,497 |
$0.00 |
| G8839 |
Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness |
637 |
561 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
297 |
190 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
1,047 |
696 |
$0.00 |
| 1036F |
|
2,919 |
1,930 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
541 |
345 |
$0.00 |
| 1157F |
|
564 |
512 |
$0.00 |
| 1125F |
|
2,002 |
1,704 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
1,180 |
826 |
$0.00 |
| 1170F |
|
148 |
129 |
$0.00 |
| G8708 |
Patient not prescribed antibiotic |
44 |
26 |
$0.00 |
| G8410 |
Footwear evaluation performed and documented |
25 |
25 |
$0.00 |
| 3017F |
|
19 |
14 |
$0.00 |
| 4004F |
|
1,798 |
1,181 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
2,465 |
1,698 |
$0.00 |
| 3016F |
|
1,365 |
838 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
4,075 |
2,672 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
10,244 |
6,481 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
8,714 |
5,323 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
3,694 |
2,581 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
6,106 |
4,354 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
961 |
622 |
$0.00 |
| 3210F |
|
561 |
384 |
$0.00 |
| 1160F |
|
442 |
373 |
$0.00 |
| 0521F |
|
1,049 |
925 |
$0.00 |
| 0518F |
|
586 |
424 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
2,886 |
1,860 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
12,462 |
7,702 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
3,523 |
2,534 |
$0.00 |
| 90734 |
|
21 |
12 |
$0.00 |
| 1158F |
|
564 |
512 |
$0.00 |
| 3288F |
|
2,616 |
1,860 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
180 |
120 |
$0.00 |
| 1159F |
|
442 |
373 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
991 |
750 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
40 |
29 |
$0.00 |
| 94664 |
|
40 |
36 |
$0.00 |
| 1100F |
|
19 |
14 |
$0.00 |
| 1090F |
|
182 |
138 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
107 |
73 |
$0.00 |
| 90649 |
|
19 |
14 |
$0.00 |
| M1189 |
Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed |
13 |
13 |
$0.00 |